The July 2017 release of eTG Complete is now available and includes updated Pharmaceutical Benefits Scheme (PBS) information. If a drug is available on the PBS, there is an icon beside the dosing information in the blue dose panels. Click on the icon to check for information on PBS restrictions, brand names, pack sizes, number of repeats, and links to product information (PI) and consumer medicines information (CMI).
MIMS are updating medicine ingredient names as part of a push to support the Therapeutic Goods Administration (TGA) project to harmonise with names used internationally.
MIMS will begin referring to these ingredients by their International Non-proprietary Names (INNs), however, users may continue to search by the old Australian Approved Names (AANs) if preferred.
A cumulative list of the changes can be found here: http://mims.com.au/index.php/news/ingredient-name-changes
CKN is currently still in negotiations with Springer Publishing regarding continued access to Medications & Mothers' Milk. The subscription expiry message currently posted on the product’s website does not relate to CKN and should be ignored.
Questions regarding the product should be directed to the CKN Help Desk not Springer.
Please contact CKN Support on 1300 308 174 or support@ckn.org.au.
Three new medicine profiles clobetasol, povidone iodine and wood tars have been added.
A new therapeutic group: Medicines for the treatment of head lice has been added to the website. This aims to provide general advice on the use of targeted agents in pregnancy and breastfeeding.
All twenty-nine obstetric and gynaecological medcine profiles and twenty-nine respiratory medicine profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.
ISABEL has upgraded their platform to provide a better mobile access experience. The changes allow you access to a fully compatible system on your mobile devices, laptops, tablets, etc. In addition, the latest version provides access to more robust resources like Merck Manual Professional and Medscape on all devices. You can use new features like the Likelihood Indicator as well as take advantage of the Causative Drugs feature on all devices.
An app is no longer required for mobile access. Simply access ISABEL from the CKN website on your phone or tablet from the Point of Care page. You will not be required to enter any additional institutional login details.
The new 7th Edition of the Australian Injectable Drugs Handbook (AIDH) is now available online on CKN.
The most comprehensive resource of its kind, the AIDH provides up-to-date information on injectable medicines that has become a vital resource supporting the day to day practice of pharmacists, clinicians
and nurses throughout Australia.
New features of the AIDH 7th Edition:
Content from the National Cancer Institute's (NCI) comprehensive source of cancer information, PDQ (Physician Data Query), is now searchable on CKN.
PDQ contains cancer information summaries on a wide range of cancer topics; drug information summaries on many cancer-related drugs and drug combinations; and dictionaries of general cancer terms, drug terms, and genetics terms. More than 14,000 full-text records are now searchable on CKN.
NCI also has several unique cancer resources, such as the NCI Drug Dictionary and NCI Dictionary of Genetics Terms.
Four new medicine profiles of atumumab, pembrolizumab, pomalidomide and vandetanib have been added online. Dosulepin (dothiepin) and doxepin medicine fact sheets have been added to the medicine profiles. All fact sheets aim to complement verbal counselling by healthcare professionals. All 60 endocrine medicine profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.
Three new medicine profiles brentuximab vedotin, enzalutamide and eribulin have been added online.
A new therapeutic group: Non-cytotoxic antineoplastics - Targeted agents has been added to the website. This aims to provide general advice on the use of targeted agents in pregnancy and breastfeeding.
All 16 allergy and anaphylaxis medicine profiles, 9 antidote medicine profiles and 18 diagnostic imaging contrast media profiles have been reviewed and updated to provide the latest information and recommendations for use in pregnancy and breastfeeding.
CKN is designed to remain operational 24/7 during extreme weather events. Even if QHEPS is temporarily unavailable at your hospital, CKN will still be accessible via the internet using a personal mobile device. If you or colleagues are not already registered for CKN mobile access, we recommend that you do so as soon as practicable. Registering is easy and only takes a few minutes.